Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, and strategic partnerships further drive expansion in this evolving sector. Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, a…
The biosimulation market is witnessing robust expansion, fueled by the increasing adoption of model-informed drug development (MIDD), the growing complexity of modern drug development, and the rising emphasis on personalized and precision medicine. MIDD strat…